Abstract
Stroke is the leading cause of disability in developed countries, and investigations to identify ways to recover lost neurological function continue. The potential of stem cell therapy could be enormous, but current knowledge and techniques remain limited. In this review article, findings related to the therapeutic potential of acceleration of endogenous neurogenesis and neuronal stem cell transplantation are introduced. The therapeutic effects of acceleration of endogenous neurogenesis have been shown to be mild, but they improve neurological function significantly, and clinical trials are ongoing. In contrast, the potential of neural stem cell transplantation has been reported in many basic experiments, but current basic knowledge and techniques are likely to be insufficient to proceed to clinical trials. The possible missing elements for successful neuronal stem cell transplantation in patients with cerebral infarction are discussed.
Keywords: angiogenesis, cell therapy, cerebral infarction, clinical trial, neural stem cells, neurogenesis, stroke, subventricular zone, vascular endothelial growth factor, granulocyte colony-stimulating factor, brain-derived neurotrophic factor, erythropoietin, endothelial stem/progenitor cell, embolic stem cell, induced pluripotent stem cell, CD34-positive cell, bone marrow mononuclear cell, T-lymphocyte, CD4-positive lymphocyte, CD8-positive lymphocyte, mesenchymal cell, inflammation, apoptotic cell death, immune system, therapeutic time window
Current Signal Transduction Therapy
Title: The Therapeutic Potential of Neural Stem Cells in Cerebral Ischemia
Volume: 6 Issue: 3
Author(s): Yukiko Kasahara, Takayuki Nakagomi, Akiko Nakano-Doi, Tomohiro Matsuyama and Akihiko Taguchi
Affiliation:
Keywords: angiogenesis, cell therapy, cerebral infarction, clinical trial, neural stem cells, neurogenesis, stroke, subventricular zone, vascular endothelial growth factor, granulocyte colony-stimulating factor, brain-derived neurotrophic factor, erythropoietin, endothelial stem/progenitor cell, embolic stem cell, induced pluripotent stem cell, CD34-positive cell, bone marrow mononuclear cell, T-lymphocyte, CD4-positive lymphocyte, CD8-positive lymphocyte, mesenchymal cell, inflammation, apoptotic cell death, immune system, therapeutic time window
Abstract: Stroke is the leading cause of disability in developed countries, and investigations to identify ways to recover lost neurological function continue. The potential of stem cell therapy could be enormous, but current knowledge and techniques remain limited. In this review article, findings related to the therapeutic potential of acceleration of endogenous neurogenesis and neuronal stem cell transplantation are introduced. The therapeutic effects of acceleration of endogenous neurogenesis have been shown to be mild, but they improve neurological function significantly, and clinical trials are ongoing. In contrast, the potential of neural stem cell transplantation has been reported in many basic experiments, but current basic knowledge and techniques are likely to be insufficient to proceed to clinical trials. The possible missing elements for successful neuronal stem cell transplantation in patients with cerebral infarction are discussed.
Export Options
About this article
Cite this article as:
Kasahara Yukiko, Nakagomi Takayuki, Nakano-Doi Akiko, Matsuyama Tomohiro and Taguchi Akihiko, The Therapeutic Potential of Neural Stem Cells in Cerebral Ischemia, Current Signal Transduction Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157436211797484038
DOI https://dx.doi.org/10.2174/157436211797484038 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Mineralocorticoid Receptor Antagonists in the Management of Heart Failure with Preserved Ejection Fraction
Current Pharmaceutical Design Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued) Sea, Carbohydrates and Clotting: A Triad on the Road of Drug Discovery
Mini-Reviews in Medicinal Chemistry The Complementary Roles of Imaging and ‘Omics’ for Future Anti-Atherosclerotic Drug Development
Current Pharmaceutical Design Periodontitis, Endothelial Dysfunction and Atherosclerosis
Vascular Disease Prevention (Discontinued) Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review
Reviews on Recent Clinical Trials HCN Pacemaker Channels and Pain: A Drug Discovery Perspective
Current Pharmaceutical Design Recent Advances in Management of Diabetic Macular Edema
Current Diabetes Reviews Pulmonary Rehabilitation as Evaluated by Clinical Trials: An Overview
Reviews on Recent Clinical Trials Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Impacts of Nanoparticles on Cardiovascular Diseases: Modulating Metabolism and Function of Endothelial Cells
Current Drug Metabolism Adherence to Treatment, Arterial Stiffness and Cognitive Function in Irbesartan- Treated Newly Diagnosed Hypertensive Patients
Current Vascular Pharmacology A Survey on Left Ventricle Segmentation Techniques in Cardiac Short Axis MRI
Current Medical Imaging Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin
Current Medicinal Chemistry Pain and Obesity in the Older Adult
Current Pharmaceutical Design Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Current Drug Abuse Reviews The Role of microRNAs in the Development of Type 2 Diabetes Complications
Current Pharmaceutical Design A Review of Premature Frailty in HIV-Infected Persons; Another Manifestation of HIV-Related Accelerated Aging
Current Aging Science The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation
Current Drug Targets - Cardiovascular & Hematological Disorders Derivatives of 1,2,3,4-tetrahydroisoquinoline-7-carboxylic Acid as Novel Fibrinogen Receptor Antagonists
Medicinal Chemistry